THOMAS SCHNEIDER: Open Payments
NPI 1043720394 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 10 payments from 9 companies in 2025. Trend: 2023 $67 · 2024 $46 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Recor Medical Inc | 1 | $26 |
| Novo Nordisk Inc | 1 | $22 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Chiesi USA, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: EVKEEZA, LEQVIO, Paradise Ultrasound Renal Denervation System, Rybelsus, FUROSCIX, Kerendia, CLEVIPREX, FARXIGA.
Industry payments across NY — which companies pay providers there.
